Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
Conditions
- Non-clear Renal Cell Carcinoma
Interventions
- DRUG: Toripalimab
- DRUG: Axitinib
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School